The Impact of Raising Children with Barth Syndrome on Parental Health-Related Quality of Life and Family Functioning: Preliminary Reliability and Validity of the PedsQL™ Family Impact Module. [PDF]
Lim Y, Hong I, Han A.
europepmc +3 more sources
Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome. [PDF]
Hornby B +6 more
europepmc +3 more sources
Reduction in mRNA Expression of the Neutrophil Chemoattract Factor CXCL1 in Pseudomonas aeruginosa Treated Barth Syndrome B Lymphoblasts. [PDF]
Zegallai HM, Duan K, Hatch GM.
europepmc +3 more sources
Hypogammaglobulinaemia and B cell lymphopaenia in Barth syndrome. [PDF]
Kudlaty E, Agnihotri N, Khojah A.
europepmc +3 more sources
Granulopoietic Dysregulation in a Patient-Tailored Mouse Model of Barth Syndrome. [PDF]
Sierra Potchanant EA +12 more
europepmc +3 more sources
Integrated multi-omics mapping of mitochondrial dysfunction and substrate preference in Barth syndrome cardiac tissue. [PDF]
Schomakers BV +18 more
europepmc +3 more sources
Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome. [PDF]
Raghav R +5 more
europepmc +3 more sources
Heart injury in Barth syndrome
I. V. Leontyeva +2 more
openalex +3 more sources
Experimental models of Barth syndrome. [PDF]
AbstractMutation of the gene Tafazzin (TAZ) causes Barth syndrome, an X‐linked disorder characterized by cardiomyopathy, skeletal muscle weakness, and neutropenia. TAZ is an acyltransferase that catalyzes the remodeling of cardiolipin, the signature phospholipid of the inner mitochondrial membrane. Here, we review the major model systems that have been
Pu WT.
europepmc +3 more sources

